Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 1:187:108499.
doi: 10.1016/j.neuropharm.2021.108499. Epub 2021 Feb 16.

Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders

Affiliations
Review

Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders

MacKenzie R Peltier et al. Neuropharmacology. .

Abstract

Stress and trauma exposure disturbs stress regulation systems and thus increases the vulnerability for stress-related disorders which are characterized by negative affect, including major depressive disorder, anxiety disorders and posttraumatic stress disorder. Similarly, stress and trauma exposure results in increased vulnerability to problematic alcohol use and alcohol use disorder, especially among women, who are more likely to drink to cope with negative affect than their male counterparts. Given these associations, the relationship between stress-related disorders and alcohol use is generally stronger among women leading to complex comorbidities across these disorders and alcohol misuse. This review highlights the therapeutic potential for progestogen- and androgen-derived neurosteroids, which affect both stress- and alcohol-related disorders, to target the overlapping symptoms related to negative affect. This article is part of the special issue on 'Vulnerabilities to Substance Abuse.'

Keywords: Alcohol; Androgen-derived; Neurosteroids; Progestogen-derived; Sex differences; Stress-related disorders.

PubMed Disclaimer

References

    1. Allen SS, Allen AM, Lunos S, & Tosun N (2016a). Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial. Nicotine & Tobacco Research, 18(11), 2145–2153. 10.1093/ntr/ntw156 - DOI - PMC - PubMed
    1. Allen AM, McRae-Clark AL, Carlson S, Saladin ME, Gray KM, Wetherington CL, McKee SA, & Allen SS (2016b). Determining menstrual phase in human biobehavioral research: A review with recommendations. Experimental and Clinical \Psychopharmacology, 24(1), 1–11. 10.1037/pha0000057 - DOI - PMC - PubMed
    1. Altemus M, Sarvaiya N, & Neill Epperson C (2014). Sex differences in anxiety and depression clinical perspectives. Frontiers in Neuroendocrinology, 35(3), 320–330. 10.1016/j.yfrne.2014.05.004 - DOI - PMC - PubMed
    1. Angold A, Costello EJ, Erkanli A, & Worthman CM (1999). Pubertal changes in hormone levels and depression in girls. Psychological Medicine, 29(5), 1043–1053. 10.1017/s0033291799008946 - DOI - PubMed
    1. Baischer W, Koinig G, Hartmann B, Huber J, & Langer G (1995). Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology, 20(5), 553–559. 10.1016/0306-4530(94)00081-k - DOI - PubMed

Publication types